Cancers | Free Full-Text | Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
JCI Insight - Metastasis regulation by PPARD expression in cancer cells
Marizomib inhibit tumor growth in syngeneic 4T1.2 murine model of TNBC... | Download Scientific Diagram
Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach | ACS Omega
Imagable 4T1 model for the study of late stage breast cancer | BMC Cancer | Full Text
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors | Journal for ImmunoTherapy of Cancer | Full Text
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
The growth curve of 4T1 tumors in TNBC mouse model in different time... | Download Scientific Diagram
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation: Molecular Therapy
CT26 Syngeneic Mouse Model - Altogen Labs
JCI - TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation
Frontiers | Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
CC inhibits in vivo tumor growth and lung metastasis in 4T1-syngeneic... | Download Scientific Diagram
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy | Journal for ImmunoTherapy of Cancer
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
New shuttle session with our in vivo syngeneic tumor models – for cost-saving efficacy studies - by Explicyte Immuno-Oncology
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
4T1 Syngeneic Murine Model - Altogen Labs
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
BH is effective in TNBC tumor model. On day 8, 4T1 tumor model mice... | Download Scientific Diagram
In-vivo antitumor activity of compound 19 in a syngeneic (4T1 induced)... | Download Scientific Diagram
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer | npj Breast Cancer
